Emerging diseases resource center

Welcome to the American Academy of Dermatology’s hub for emerging diseases. The Academy’s Emerging Diseases Task Force has curated and developed these scientific resources to assist members in the recognition, management, and reporting of emerging threats. Please check back regularly for disease alerts and new resources.
Access our registry for emerging diseases, including mpox, dermatophytosis, and COVID-19.
Access information and resources on Alpha-gal syndrome.
Access information and resources on viral trends.
Access information and resources on Dermatophilosis.
Access information on various vaccine-preventable diseases.
Access information on viral hemorrhagic fevers, such as hantavirus.
Learn about the current measles outbreak, recognizing measles, vaccine information, and more.
Access our information on antimicrobial-resistant and other emerging dermatophytes.
Access clinical guidance from the Academy and the CDC on recognizing and treating mpox.
Access our information on biologics or the COVID-19 dermatology registry.
CDC request for cases of severe chromoblastomycosis
Dear Dermatologist,
I am reaching out from the Laboratory of Clinical Immunology and Microbiology at the NIH/NIAID regarding chromoblastomycosis. Our group has been developing translational research efforts focused on the immunopathogenesis of severe and refractory chromoblastomycosis, and emerging data from these studies suggest that targeted adjunct immunomodulatory approaches may have the potential to help induce clinical remission in selected individuals with difficult-to-treat disease.
To date, much of our clinical experience and collaborations have involved cases outside the United States. We would be very interested in connecting with dermatologists in the US who may currently care for individuals with severe, refractory, extensive, or relapsing chromoblastomycosis, particularly cases with suboptimal responses to conventional antifungal and/or surgical approaches.
Our goal would be to establish collaborative discussions regarding such cases, with the possibility of patient evaluation through NIH clinical research protocols, and consideration of investigational therapeutic approaches where appropriate.
If you are aware of such patients or interested in discussing further, please feel free to contact me directly at lionakism@niaid.nih.gov.
Best regards,
Michail S. Lionakis, MD, ScD
Chief, Laboratory of Clinical Immunology and Microbiology
Chief, Fungal Pathogenesis Section
NIAID/NIH
Alert us to emerging diseases
Use our form to alert the Academy’s task force to an emerging disease.
Submit emerging diseaseSTI / STD resources
Download a PDF of our resources on sexually transmitted infections / diseases.
Access PDFAlerts and brief updates
Below is a list of links and limited information about various emerging diseases.
Ebola
Hantavirus
Mpox
Drug-resistant tinea
Resistant Trichophyton indotineae Dermatophytosis — An Emerging Pandemic, Now in the U.S.
Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII
First U.S. Case of Sexually Transmitted Fungal Infection Found in New York City
Find a Dermatologist
Member directory
AAD Learning Center
2027 AAD Annual Meeting
Need coding help?
2027 Coding Resources
Clinical guidelines
Why use AAD measures?
New insights
Physician wellness
Joining or selling a practice?
Promote the specialty
Advocacy priorities